Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY47.59 CNY
Change Today -0.70 / -1.45%
Volume 3.9M
600211 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

tibet rhodiola pharm-a (600211) Snapshot

Open
CNY48.20
Previous Close
CNY48.29
Day High
CNY49.78
Day Low
CNY47.30
52 Week High
04/17/15 - CNY49.78
52 Week Low
05/19/14 - CNY19.99
Market Cap
6.9B
Average Volume 10 Days
5.2M
EPS TTM
CNY0.15
Shares Outstanding
145.6M
EX-Date
--
P/E TM
320.9x
Dividend
CNY0.05
Dividend Yield
0.13%
Current Stock Chart for TIBET RHODIOLA PHARM-A (600211)

Related News

No related news articles were found.

tibet rhodiola pharm-a (600211) Related Businessweek News

No Related Businessweek News Found

tibet rhodiola pharm-a (600211) Details

Tibet Rhodiola Pharmaceutical Holding Company is engaged in the production and distribution of pharmaceuticals in China. The company wholesales pharmaceuticals, as well as distributes proprietary drug products. It has operations primarily in southwest China, Beijing, Shanghai, Guangdong province, and other regions. The company was founded in 1999 and is based in Lhasa, China.

Founded in 1999

tibet rhodiola pharm-a (600211) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tibet rhodiola pharm-a (600211) Key Developments

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. Proposes 2014 Profit Distribution Plan

Tibet Rhodiola Pharmaceutical Holding Company announced at its annual general meeting to be held on April 16, 2015, it will propose a cash dividend of CNY 0.50000000 per 10 shares (tax included).

Tibet Rhodiola Pharmaceutical Holding Company, Annual General Meeting, Apr 16, 2015

Tibet Rhodiola Pharmaceutical Holding Company, Annual General Meeting, Apr 16, 2015., at 14:30 China Standard Time. Agenda: To consider 2014 annual report and its summary; to consider 2014 work report of the board of directors; 2014 financial resolution report; to consider 2014 profit distribution plan; to consider reappointment of 2015 audit firm; to consider continuing connected transactions estimate; to consider 2014 work report of the supervisory committee; and to approve amendments to the company's rules of procedures governing meetings of the supervisory committee.

Tibet Rhodiola Pharmaceutical Holding Company Reports Earnings Results for the Full Year of 2014

Tibet Rhodiola Pharmaceutical Holding Company reported earnings results for the full year of 2014. For the year, the company's basic earnings per share were CNY 0.144, and weighted average return on net assets was 5.13%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600211:CH CNY47.59 CNY -0.70

600211 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600211.
View Industry Companies
 

Industry Analysis

600211

Industry Average

Valuation 600211 Industry Range
Price/Earnings 100.0x
Price/Sales 4.2x
Price/Book 17.2x
Price/Cash Flow 330.6x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIBET RHODIOLA PHARM-A, please visit www.xzyy.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.